Publication Name	World Journal of Cardiology
Manuscript ID	100046
Country	China

Received	2024-08-06 02:42
Peer-Review Started	2024-08-06 02:42
To Make the First Decision
Return for Revision	2024-09-17 06:05
Revised	2024-09-21 08:48
Second Decision	2024-11-06 02:41
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-11-06 07:08
Articles in Press	2024-11-06 07:08
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-11-12 01:24
Publish the Manuscript Online	2024-11-26 09:16

ISSN	1949-8462 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Letter to the Editor
Article Title	Comparative breakthrough: Umbilical cord mesenchymal stem cells vs bone marrow mesenchymal stem cells in heart failure treatment
Manuscript Source	Invited Manuscript
All Author List	Peng Li
ORCID	Author(s) ORCID Number Peng Li http://orcid.org/0000-0002-9153-2955
Funding Agency and Grant Number	Funding Agency Grant Number National High Level Hospital Clinical Research Funding Project BJ-2023-206
Corresponding Author	Peng Li, MD, Department of Geriatics, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, No. 1 Dongdan, Dahua Road, Dongcheng District, Beijing 100730, China. lipbenzi@126.com
Key Words	Mesenchymal stem cells; Heart failure; Umbilical cord-derived mesenchymal stem cells; Bone marrow-derived mesenchymal stem cells; Left ventricular ejection fraction; 6-minute walking distance; Cardiac regeneration therapy
Core Tip	This article provides a comparative analysis of umbilical cord-derived mesenchymal stem cells (UC-MSCs) and bone marrow-derived mesenchymal stem cells (BM-MSCs) for the treatment of heart failure. UC-MSCs significantly increase left ventricular ejection fraction and exhibit a favorable safety profile, positioning them as a promising alternative to BM-MSCs. Future research should focus on optimizing administration protocols and understanding the long-term benefits of UC-MSCs in cardiac therapy.
Publish Date	2024-11-26 09:16
Citation	<p>Li P. Comparative breakthrough: Umbilical cord mesenchymal stem cells vs bone marrow mesenchymal stem cells in heart failure treatment. <i>World J Cardiol</i> 2024; 16(12): 776-780</p>
URL	https://www.wjgnet.com/1949-8462/full/v16/i12/776.htm
DOI	https://dx.doi.org/10.4330/wjc.v16.i12.776

Full Article (PDF)	WJC-16-776-with-cover.pdf
Manuscript File	100046_Auto_Edited_034054.docx
Answering Reviewers	100046-answering-reviewers.pdf
Audio Core Tip	100046-audio.mp3
Conflict-of-Interest Disclosure Form	100046-conflict-of-interest-statement.pdf
Copyright License Agreement	100046-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	100046-foundation-statement.pdf
Non-Native Speakers of English Editing Certificate	100046-non-native-speakers.pdf
Peer-review Report	100046-peer-reviews.pdf
Scientific Misconduct Check	100046-scientific-misconduct-check.png
Scientific Editor Work List	100046-scientific-editor-work-list.pdf
CrossCheck Report	100046-crosscheck-report.pdf